AFTER THE 20th_BEF
> RECORDINGS
​> PRESENTERS
​> ATTENDEES
> INVESTORS​​​​​
> SPONSORS​​
> SUPPORTERS​

PARTICIPATING COMPANIES IN 2020 INCLUDE:

AbbVie Ventures
AbbVie, Inc.
Ability Pharmaceuticals, SL
Accent Advisors
Accure Therapeutics S.L.
Actelion, a Janssen Pharmaceuticals Company of Johnson & Johnson
Acticor Biotech SAS
Actinium Pharmaceuticals, Inc.
ACXIT Capital Management GmbH
Additio Investment Group
Advanced Marker Discovery, S.L. (Amadix)
Advent Life Sciences
Aglaia Oncology Funds
Aisling Capital LLC
Aleta Biotherapeutics
ALISEI Life Science Cluster
Alpha Bronze
ALSA Ventures
Alta Life Sciences
Alzheimer's Research UK
Amazon Web Services EMEA SARL
Amryt Pharma Plc
Ancora.ai AG
Andera Partners
ANeuroTech, a division of ANIMA bvba
Anocca AB
Apogenix AG
Apollo Health Ventures
Aqua Partners LLC
Arbor Pharmaceuticals, LLC
ARCH Venture Partners
Ardigen S.A.
Arix Bioscience Plc. 
Arrowfield Capital
ARTHEx Biotech S.L.
ARTO AG
Arvelle Therapeutics
Ascenion GmbH
Asklepios Advisors
Astellas Pharma, Inc.
AstraZeneca
Astrocyte Pharmaceuticals, Inc.
ATAI LIfe Sciences
ATEM Capital LLC
ATGN Consulting
Axovant Gene Therapies
Bank Julius Baer & Co. Ltd.
BaselArea Business & Innovation
BaseLaunch
Bavarian Capital Management
Bay City Capital LLC
BB Pureos Bioventures
BCG Digital Ventures
BeiGene Ltd.
BerGenBio ASA
Bergmann zur Hausen & Cie. GmbH
Berlin Partner für Wirtschaft und Technologie GmbH
Berlin-Chemie AG
BestHealth4U
Bio Med Gene Ventures
BioBac BioValley Business Angels Association
Biocoast Capital
BioEclipse Therapeutics, Inc.
BioGeneration Ventures
BioMedPartners AG
BioPharma Advisory
Bioqube Ventures
BioScience Managers Pty Ltd.
BIOSTART Consulting GmbH
BioVersys AG
Bloomberg Intelligence
BOCAhealthcare GmbH
Boltendahl International Partners
Bone Therapeutics SA
Bootstrap Europe SCSP
Boston Consulting Group
Boston Financial LLC
Bpifrance
Bradley Woods & Co. Ltd.
Brenus Pharma
BRESLIN AG
Bridge Valley Ventures LLP
BROTHERS & PARTNERS EUROPE
Bryan, Garnier & Co Ltd.
BTIG, LLC
Caixa Capital Risc
CALIXAR
Calliditas Therapeutics AB
Camel-IDS
Canaccord Genuity LLC
Canica Holding AG
Cansativa GmbH
Canton of Basel-Stadt
Cantourage GmbH
CapEval Pharma
Capital Grand Est
Capricorn Partners NV
Carisma Therapeutics Inc.
CDR-Life Inc.
Cederberg GmbH
CellmAbs
Cello Health BioConsulting
Celyad Oncology SA
Citigate Dewe Rogerson
Claris Ventures
Clave Mayor S.G.E.I.C., S.A.
Clavis Capital Ltd.
Clearview Capital
Click Therapeutics, Inc.
CMS Medical Venture and A&B Fund
Cofes France SAS
Cognoptix, Inc.
Collaborative Community against Coronavirus (3C)
Colpman Consulting Ltd.
coparion GmbH & Co. KG
Corinthian FInancial Management Ltd.
Coulter Partners
CRIAM
Crosswave Management
Csendes Consulting
CTI Life Sciences
Cukierman & Co. Life Sciences
DCPrime B.V.
DeBere Capital Partners
Decision Resources, Inc.
Decoy Biosystems, Inc.
Delta 4 GmbH
Dementia Discovery Fund
Digital Networks Plc. S.r.l.
Dishman Europe Ltd.
Dolby Family Ventures, L.P.
Domain Therapeutics SA
Dr. Pfleger Arzneimittel GmbH
Droplite Technologies, S.L.
Dyadic International, Inc.
EA Pharma Co., Ltd.
Edison Group
Eight Roads Ventures Japan
Eir Ventures AB
EIT Health e.V.
eleva GmbH
Eli Lilly and Company
EMD Serono
ENDOBIOS Unipessoal Lda
Epidarex Capital
Epsilogen Ltd.
ErfindungsVerwertung AG (EVA)
Ernst & Young AG
ESC Advisors
Euronext Paris S.A.
European Investment Bank
European Investment Fund
European Medical Cannabis Association (EUMCA)
Evora Biosciences SAS
Exscientia Ltd.
F. Hoffmann-La Roche Ltd.
Ferghana Partners
Fondazione Toscana Life Sciences
Forbion
Forendo Pharma Ltd.
Fortunatus Capital
Fraser Finance
Freeline Therapeutics Ltd.
FreeMind Group
Fundplus NV
FutuRx Ltd.
FYZICAL Therapy
G Integration
G4S Capital
GCF Family Office
Generation Capital, LLC
Genomill Health
Gilde Healthcare Partners
Gimv NV
GL Capital
GliXogen Therapeutics Ltd.
Global Founders Capital GmbH
Global Investment Bridge AG
Global Neurohealth Ventures
Grabulovski Consulting Services GmbH
Gravitas Global Advisors LLC
GreenSky Capital, Inc.
Gritstone Oncology, Inc.
GrowthCube Partners
GSK
Guoqian VC
H.C. Wainwright & Co., LLC
Hadean Ventures AS
Handskjeik
HBM Partners AG
Health Passion Fund
HealthCap
Helsinn International Services Sarl
High-Tech Gründerfonds Management GmbH
HiQ-Nano s.r.l.
HitchinRock Advisors Limited
Hovione Capital, Sociedade de Capital de Risco, SA
i&i Prague, s.r.o.
i2020 Accelerator
Iaso Ventures
ICF Consult (Switz.)
Ieso Digital Health Ltd. 
Ignite Capital Partners, Inc.
Illumina Ventures
ILTOO Pharma
Image Analysis Group
IMI Consulting GmbH
Immunicum AB
IMV Inc.
Inbio Ventures
Indaco Venture Partners SGR SpA
Indicate Solutions S.L.
Industrifonden
INKEF Capital BV
INNOventure Sp. z o.o.
Inserm Transfert Initiative/Sofimac
InSitu Therapeutics
InterAx Biotech AG
Inventiva Pharma
Inveready
IPF Partners
Italian Trade Agency (ITA) 
J.P. Morgan
Janssen Vaccines & Prevention B.V.
Jefferies International Ltd.
JFG Stiftung
JIH Vermögensverwaltungs GmbH
Jina Ventures Inc.
​Johns Hopkins All Children's Hospital

Johnson & Johnson Innovation – JJDC, Inc.
Johnson & Johnson Innovation | Janssen Business Development
Johnson & Johnson Innovation LLC
Joyance Partners
JT Pharma
Justin Stindt Consulting GmbH
Kaken Pharmaceutical Co., Ltd.
Katan Associates, Inc.
Kempen & Co
Khiron Life Sciences Corp.
Kinarus AG
KIZOO Technology Capital GmbH
Krakowski Park Technologiczny sp. z o.o.
Kreos Capital
KU Leuven
Kurma Partners SA
Kyme NanoImaging Srl
Landmark Angels, Inc.
Latham & Watkins LLP
LifeCare Partners AG
LifeSci Advisors
Lilly Asia Ventures
LimmaTech Biologics AG
LMU Munich
Locust Walk
Longevity Biotech, Inc.
Longliv Ventures
Lonza AG
LSP
Lundbeckfonden Ventures
M Ventures
M&G Advisors GmbH
Mass General Brigham Ventures
Medicover AB
Medicover Integrated Clinical Services Sp. z o.o.
Medicxi
MedinCell S.A.
MedPro Investors LLC
Memo Therapeutics AG
MercachemSyncom
Merck
Merck KGaA
Met Syn Lysine Ltd.
Metys Pharmaceuticals AG
Microbiotica Ltd.
Mid Atlantic Bio Angels
Millhouse
Mirabaud Securities Ltd.
Mitsubishi Tanabe Pharma Europe Ltd.
Mitsui Global Investment, Inc.
Modra Pharmaceuticals B.V. 
Molsid S.A.S.
Momentum Biotech
MOWOOT
MPM Capital, Inc.
MSD
MSQ Ventures
munevo GmbH
MV BioTherapeutics SA
Nasdaq
National Institutes of Health
NeuroRx, Inc.
Neurotech Reports
New Enterprise Associates (NEA)
New Harbor Venture Partners, LLC
Nextech Invest Ltd.
NGT3
NI Research Inc.
Nia Health GmbH
NLC Capital
Northern Light Venture Capital 
NOVADIP Biosciences
NovaQuest Capital Management
Novaremed AG
Novartis International AG
Novartis Venture Fund
Novo Holdings A/S
Novo Ventures
NOXXON Pharma NV
NRW Bank
Nussir AS
Nuventra Pharma Sciences
NxR Biotechnologies GmbH
o2h Ventures Ltd.
Oasmia Pharmaceutical AB
OCA Ventures
Oculis SA
Oddo BHF
Office of Economy and Labour, Canton of Basel-Stadt
Omnes Capital
OncoDesign SA
OrbiMed Advisors LLC
Oryzon Genomics
Oryzon Genomics S.A.
Otsuka Pharmaceutical Europe Ltd.
Oxford Finance, LLC
Panacea Venture
Panakès Partners SGR SpA
Parkinson's UK
PatchAi Srl
PEP-Therapy
Percipient Capital
Perseo Pharma AG
Pfizer, Inc.
PharmaVentures Ltd.
Pharmstandard JSC
Plich Advisory & Investments B.V.
Plusimple S.r.l.
Polish Center for Technology Development
PolyGlyco Biotech GmbH 
Pontifax Venture Capital
Portugal Ventures SCR, SA
Positive Capital
Prevail Partners LLC
Priavoid GmbH
Prokarium Ltd.
QIAGEN GmbH
Quan Capital
RA Capital Management, L.P
Raymond James
RBV Capital
Recursion Pharmaceuticals
Redalpine Venture Partners
RedHill Biopharma Ltd.
Remiges Ventures
Roche Venture Fund
Roivant Sciences GmbH
Royal Bank of Canada
RubrYc Therapeutics, Inc.
RYSE Asset Management
Sanan Capital
Sand Hill Angels
Sandoz GmbH
SBI JI Innovation Advisory Ltd.
Schroder Adveq Management AG
Schwarz Financial Communication
Self employed - Investor
Selmod GmbH
Selvita S.A.
Seroba Life Sciences
Seventure Partners
Shaw Strategic Capital
Siemens Healthineers AG
Sigilon Therapeutics, Inc.
Silicon Valley Bank
SIX Swiss Exchange AG
Sixty Degree Capital
Sofinnova Investments
SonoClear AS
SOTIO a.s.
SphingoTec GmbH
Staatz Business Development & Strategy
STALICLA S.A.
Star Tree Ventures Ltd.
Starlight Investments LLC
SternAegis Ventures
Stifel Financial Corp.
Stingray Therapeutics, Inc.
Strategic Transactions Advisory AG
Stratos Bio AG
Sunbo Partners Europe GmbH
Swiss Biotech Association
Swiss Tech Capital AG
Synairgen Plc
Syneos Health, LLC
Taiho Ventures, LLC
Takeda Pharmaceuticals Co., Ltd.
Tandem Ventures Srl
TargetGene Biotechnologies Ltd.
TargImmune Therapeutics AG
The Centre for Addiction and Mental Health (CAMH)
The Fulford Group Ltd.
The German Accelerator Life Sciences (GALS)
The Janssen Pharmaceutical Companies of Johnson & Johnson
The Leukemia & Lymphoma Society
The Michael J. Fox Foundation for Parkinson's Research
Thermo Fisher Scientific
TiCure
Tollys
TOLREMO Therapeutics AG
Topadur Pharma AG
Torreya Partners LLP
Toscana Life Sciences Foundation
TransPacific Venture Capital Partners
Tribeca Companies
TRINITY Life Sciences GmbH
TRIO Pharmaceuticals, Inc.
TruVenturo GmbH
TVM Capital Life Science Venture Capital
TVM Life Science Management GmbH
Twin Oaks Capital, LLC
UCB Pharma
UCB Ventures
UCL Technology Fund
Unicorn Capital Partners
US Global Capital, LLC
Valor Management S.A.
valuationLAB AG
Vaxart, Inc.
V-Bio Ventures
Ventac Partners A/S
Venture Centre of Excellence
Venture Valuation AG
Versant Ventures
Vesalius Biocapital Sàrl
VI Partners AG
Vickers Venture Partners
VIOPAS Partners 
Virometix AG
Virtus Inspire Ventures
Vista Capital Advisors, LLC
Viva Bioinnovator
Vogel BioC
Wellington Partners
Whale Bay & Co
WhiteLab Genomics
Wille Finance AG
WMT AG
Xcell Medical Solutions, S.L
Xnergy Financial
XOventure GmbH
Yorkville Advisors Global, LP
Ysios Capital
Zambon S.p.A.
ZKB (Zürcher Kantonalbank)


​
​
​More TBA...​

Last updated on: 18th of September, 2020